ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

June 12, 1992

AACR Honorary Memberships; ASCO Awards

July 20, 1990